More than 2 million veterans are living with atherosclerotic cardiovascular disease (ASCVD) and require management of their high cholesterol, according to the Department of Veterans Affairs (VA). Left unaddressed, high cholesterol ...
Mar 21, 2023
0
8
If you have not heard of peripheral artery disease, or PAD, you are not alone. While clinicians and health organizations have made headway in raising awareness that heart disease is the No. 1 cause of death worldwide, PAD—despite ...
Jul 14, 2022
0
33
A team of researchers at the University of Minnesota Medical School recently proved the ability to grow human-derived blood vessels in a pig—a novel approach that has the potential for providing unlimited human vessels ...
Mar 11, 2020
0
112
More than two in three adults in the United States are considered overweight or obese, with substantial biomedical and clinical evidence suggesting that chronic overconsumption of a "western diet" - foods consisting high ...
Jan 11, 2017
0
96
(HealthDay)—Glaucoma affects more than three million Americans, but that number is expected to surge to more than four million by 2030, according to the Glaucoma Research Foundation.
Jan 9, 2017
0
0
The laboratory of Dr. Jayakrishna Ambati of the University of Kentucky College of Medicine and an international team of researchers from Italy, United Kingdom, Japan, France, The Netherlands, Australia, Sweden and Czech Republic, ...
Jan 29, 2016
0
9
Alzheimer's disease (AD), affecting millions worldwide, is the leading cause of dementia The prevalence of AD is rapidly increasing, and will possibly affect over 100 million people by 2050, yet there are no effective therapies ...
Oct 29, 2015
0
33
Currently, there are more than 350 million type 2 diabetics and according to the World Health Organization (WHO) by 2030 it will be the 7th leading cause of death worldwide.
Jun 18, 2015
0
46
Researchers at the University of Surrey have discovered how the receptors responsible for contractions in the bladder, regulate the body's clock genes.
Aug 21, 2014
0
0
Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder Neurofibromatosis 1 (NF1).
Dec 10, 2012
0
1
